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ABSTRACT
Background Increased electronic prescribing (eRx)
rates have the potential to prevent errors, increase
patient safety, and curtail fraud. US Federal mean-
ingful use guidelines require at least a 40% elec-
tronic prescribing rate.
Objective We evaluated eRx rates among primary
care providers in New York City in order to deter-
mine trends as well as identify any obstacles to
increased eRx rates required by meaningful use
guidelines.
Methods The datawe analysed included automatic
electronic data transmissions from providers en-
rolled in the Primary Care Information Project
(PCIP) from 1 January 2009 to 1 July 2010 and
follow-up telephone calls to a subset of these pro-
viders to identify potential barriers to increased eRx
usage.
Results Over the course of the study, these pro-
viders increased the eRx rate from 12.9 to 27.5%,
with an average rate of 24.1%. Conversations with
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Introduction
Medication errors are one of the primary forms of
medical errors in theUS.1–3 Becausemany preventable
medication errors occur at the drug ordering stage,4
clinical computer systems have been seen as an op-
portunity to prevent these errors. In fact, electronic
prescribing (eRx) has been shown to reduce medi-
cation errors5–7 by as much as ninefold.8 eRx not only
ensures that medication orders are legible, but by
originating prescriptions from an electronic health
record (EHR) system, such orders can also be checked
for drug–drug and drug–allergy interactions prior to
submission. eRx also increases physician adherence to
medication formularies, reducing overall healthcare
costs.9,10 TheUS federal government has accepted that
increased eRx is beneﬁcial to providers and patients.
In fact, in July 2010, the Center for Medicare and
Medicaid Services established the Final Rule formean-
ingful EHR use, and set as a criterion that providers
must transmit 40% of permissible prescriptions elec-
tronically. A study of incentivised eRx in Massachusetts
found that barely half of providers achieved this
level.11
Since 2005, the Primary Care Information Project
(PCIP) at the New York City Department of Health &
Mental Hygiene has succeeded in helping providers
adopt EHRs and is now the largest community based
EHR programme in the country.12,13 As part of the
vision to improve population health, PCIP has estab-
lished an electronic network that receives aggregated
preventive care measures from 376 practices in medi-
cally underserved communities representing approx-
imately 2000 providers who have implemented an
EHR through this project. These data are aggregate
and Health Insurance Portability and Accountability
Act (HIPAA) compliant, containing no patient-level
data. This paper describes a brief assessment of the
current state of eRxwithin the PCIP inNewYork City.
The primary goal of this assessment was to determine
how providers were currently performing in relation
to the meaningful use criteria for eRx set forth in the
Final Rule, what factors, if any, were associated with
particularly high or low utilisation of eRx, and quali-
tatively assess provider perceptions about eRx.
Method
Before evaluating the baseline eRx rate in New York
City, we needed to determine the rate in other areas of
the country such asMassachusetts. After conﬁrming a
low rate, we decided to perform a literature review to
reiterate the documented beneﬁts of eRx for providers
and patients. Once we had documented the advantages
in safety, costs and time, we decided to analyse our
data in a more longitudinal manner in order to get an
idea of whether eRx rates are trending upwards or
downwards. We believed that a cross-sectional snap-
shot at one point in time would bemore limiting. A 1-
year analysis enabled us to determine whether eRx
was, in essence, becoming more popular and whether
reaching the meaningful use guidelines of 40% by the
end of 2011 is feasible.
PCIP staﬀ are instrumental in oﬀsetting the tran-
sition, cost and burden of implementing an EHR
through education, training and links to funding sources.
PCIP has assisted more than 2000 providers over the
past 3 years in adopting an EHR. The providers we
providers identiﬁed their perceived barriers to
increased eRx use as primarily patient preference
for paper prescriptions and a belief that many
pharmacies do not accept eRx.
Conclusions The data gathered from our pro-
viders indicate that there is an increasing trend in
the eRx rate to 27.5% by July 2010, but still short of
the 40%meaningful use level.However, obstacles to
increased rates remain primarily providers’ belief
that many patients prefer paper prescriptions and
many pharmacies are not yet prepared to accept
electronic prescriptions.
Keywords: electronic health records, electronic
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Key points
. eRx rates in New York City are relatively high and have been increasing over the past year and a half.
. Providers generally like eRx and see obstacles to their increased use lying with patients preferences and
pharmacies incapable of handling eRx.
. Amap of practices and pharmacies capable of receiving eRx indicates providers have several options as to
where they can send their patients to pick up a prescription sent through eRx.
Electronic prescribing rates and barriers among providers using EHRs in New York City 93
work with are primary care (internal medicine, family
medicine, paediatrics, and obstetrics/gynaecology) and
serve at least 30%ofMedicaid/uninsured patients. Every
month, 376 practices with these EHRs electronically
transmit de-identiﬁed data concerning over 40 diﬀer-
ent measures, including eRx, automatically to PCIP.
For the purposes of this study, and in alignment
with the Final Rule, an eRx was an electronically gen-
erated prescription using certiﬁed EHR technology
and transmitted to a pharmacy system. A prescription
transmitted from the EHR via fax did not qualify as an
e-prescription, since it requires manual entry of data
by a pharmacist and increases risk of error. We cal-
culated eRx rates by dividing the number of oﬃce
visits where an electronic prescription was written by
the number of oﬃce visits where a prescription was
ordered. These percentages were calculated monthly
for each provider.
We analysed eRx data, using three data sources to
complete our assessment:
1 phone and in-person surveys of 37 PCIP providers’
attitudes of eRx, as well as their perceived obstacles
to wider adoption
2 EHR database of New York City pharmacies that
accept eRx along with their addresses used in
production of a map
3 PCIP database of aggregate de-identiﬁed counts of
each provider’s EHR utilisation transmitted auto-
matically monthly from January 2009 to July 2010.
We used chi-square tests to determine whether the
number of oﬃce visits, the number of prescriptions
written and the number of support staﬀ had any
relation to the practices where eRx is >40%. We
used a cut-oﬀ of a P-value of < 0.05 to dispel the null
hypothesis. We used SPSS for statistical analysis and
graphical output.
Results
Based on survey results, providers are generally in
favour of eRx. Providers emphasised the convenience
of eRx, its potential to save time, error reduction and
improved legibility. In addition, they felt that eRx
prevented call backs from pharmacies, improved of-
ﬁce workﬂow, increased patient safety and reduced
forgery. Finally, providers felt eRx created a perma-
nent log allowing providers to check when a patient
ﬁlls a prescription and allowed tracking of the origins
of a prescription in case of an audit. Interestingly,
providers tended to overestimate their own eRx rates
primarily due to their belief that faxing a prescription
qualiﬁed as eRx.
Despite the advantages of eRx, providers see patient
preference as the primary obstacle to increased eRx
use. Providers’ reasons for patients’ desire not to use
eRx included patient distrust of eRx, patients’ uncer-
tainty concerning their pharmacy preference, patients’
desire to utilise mail-order pharmacies and proof of a
prescription that a paper prescription aﬀords. Add-
itionally, providers expressed frustration that it is not
possible to electronically prescribe durable medical
equipment, such as glucose strips, nebuliser/tubing,
surgical supplies and over-the-counter ointments.
Another obstacle to increased eRx use was the
providers’ belief that a signiﬁcant number of phar-
macies do not accept e-prescriptions or have signiﬁ-
cant delays in ﬁlling them, despite more than half
(52%) of all pharmacies accepting eRx (Figure 1).
Even when providers commit to eRx, they are often
unsure how to easily identify a pharmacy convenient
for the patient that accepts eRx.
Aggregate utilisation data from the 376 practices
between January 2009 and July 2010 indicated that
eRxwas utilised in approximately 21.7%of oﬃce visits
in which a prescription was generated, and eRx rates
increased by 0.82% each month (Figure 2). Across all
these practices, eRx rates more than doubled (12.9 to
27.5%) from the beginning of 2009, and practices that
‘went live’ on the EHR more than 1 year ago had a
higher eRx rate than those that adopted an EHR less
than 1 year ago (25.0 vs 21.6%) (Figure 3). A histo-
gram showing eRx performance by decile can be seen
in Figure 4.
Eighty-one practices have achieved the meaningful
use eRx rate >40%. These high eRx practices had a
lower support staﬀ to full-time equivalent provider
ratio of 3.6 (P= 0.02). In addition, these practices tend
to prescribe more medications, although the results
were not statistically signiﬁcant (P = 0.06; Table 1).
Discussion
Principal ﬁndings
In general, although currently low, the rate of eRx is
increasing. Our data suggest increased adoption of
eRx by the provider and patient community. The
practices with the highest rates of eRx have a number
of qualities in common. They tend to have fewer oﬃce
visits where prescriptions were written and have a
higher support staﬀ to provider ratio. Surveyed pro-
viders indicate that they generally like eRx but are
limited in its greater use by patient preference for
paper prescriptions, inability to electronically pre-
scribe durable equipment, and belief that pharmacies
are not yet ready to accept eRx.
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Implications of the ﬁndings
eRx rates have slowly been increasing despite
perceived barriers by providers, and many providers
are on course for satisfying the meaningful use re-
quirement of at least 40% eRx. Providers are begin-
ning to see the advantages of eRx, and patients are
becoming accustomed to the concept of eRx. One
potential reason for the increased eRx among pro-
viders is a number of incentive programmes oﬀered
for increased eRx use. For example, since 1 January
Figure 1 Map of PCIP practices and eRx enabled pharmacies
Figure 2 eRx rate among PCIP practices from 1 January 2009 to 1 July 2010
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Figure 4 eRx rates of PCIP practices as of July 2010. Practices who have satisﬁed the meaningful use
requirement of at least 40% ePx are represented in the graph shown above with dark shading
Figure 3 eRx percent among PCIP practices that have implemented an EHR system less than 12 months ago
compared with more than 12 months ago
Table 1 Characteristics of high and low E-prescribing practices
Metric eRx rate (monthly average) P
>40% 10–40% 1–10% 0%
No. of practices 81 120 111 64
Oﬃce visits with Rx (mean) 370 358 348 162 0.12
No. of Rx issued (mean) 1149 1161 1093 438 0.06
Support staﬀ/full-time equivalent
(mean)
3.6 3.7 3.7 3.8 0.02
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2010, eligible New York State providers can receive
$0.80 per dispensed Medicaid e-prescription, while
retail pharmacies can receive $0.20.14 Since January
2009, for theirMedicare patients, qualifying providers
may be eligible for 2% of their total allowed charges
under Medicare Part B.15
There are additional steps that can be taken to
increase the rate of eRx adoption. First, EHRs should
incorporate functionality that allows providers to search
more granularly for pharmacies to accommodate
patient preference, especially in areas where pharmacy
density is high. Patients do not often know the address
of their pharmacy or which pharmacy they prefer to
use. In an area of high pharmacy density such as New
York City, this can pose a signiﬁcant problem. Second,
the prescription of durable medical equipment (i.e.
glucose strips, nebuliser/tubing, surgical supplies and
over-the-counter ointments) must be included in the
eRx compendium. These items have been speciﬁcally
excluded from meaningful use measurements in the
Final Rule On Meaningful Use,16 however, the work-
ﬂow implications of excluding these items are critical.
Providers who want to eRx medications for patients
must use a separate paper prescription for durable
equipment, requiring two separate processes not con-
sonant with ease of workﬂow. In this case, providers
simply opt to use paper for all of the prescriptions.
Third, mail-order pharmacies need to be included as
an option for eRx. Many patients are increasingly
using mail-order pharmacies due to cost, and eRx
needs more penetration to accommodate this trend.
Fourth, increased education for patients on the ben-
eﬁts of eRx, such as increasing safety and eﬃciency
while decreasing errors, can break down many of the
myths existing in the community concerning eRx.
Finally, providers need to be educated that faxing
prescriptions does not constitute eRx. Faxing does
not aﬀord the increased patient safety and increased
legibility advantages as the pharmacist must manually
input the prescription, leaving opportunity for error.
Comparison with the literature
Our providers’ attitude toward eRx was generally
favourable, which is similar to other studies pub-
lished.17–19 While our providers generally viewed
eRx as a time saver, especially for established patients
with a lot of medications that need renewals, other
studies suggest that handwritten prescriptions are
faster.20However, these studies can be vendor-speciﬁc
and depend on the electronic software system being
used. These studies also do not take into account the
time saved from call backs from pharmacies for
illegibility or formulary issues.
The eRx rate of 24.1% was found to be closer to the
upper end of published ranges of 11–24%.21–23 The
ﬁnal rate of 27.5% in the second quarter of 2010 likely
represents an increased interest in eRx in the com-
munity because of several factors, such as meaningful
use standards, increased adoption of EHRs within
NewYork City, and a variety of incentive programmes
through New York State and the federal government.
Limitations of the method
Our sample of primary care clinics included all prac-
tices within PCIP who were capable of transmitting
their data electronically. There were a few practices
that had regular diﬃculties with their transmissions
and may not be well represented in our data. If these
practices with transmission issues also tend to be
practices with lower eRx rates, then we may be over-
estimating the actual eRx rate among PCIP practices.
This might include a bias toward practices who were
already more functional or successful and likely to use
a new technology such as eRx. In addition, because our
practices are primary care oriented, we cannot extra-
polate these eRx rates to those of specialists within
New York City.
Call for further research
Our research suggests that eRx rates are increasing
among New York City primary care providers. Future
research can continue to determine whether this trend
continues. Additional further analyses can compare
eRx rates and rates of increase by borough and patient
insurance type. Our study focused on providers per-
ceptions regarding eRx; future studies investigating
pharmacies’ and patients’ perceived barriers would be
illuminating.
Conclusions
With increased use and acceptance of eRx by pro-
viders, pharmacies, and patients, the beneﬁts of
reduced errors, increased patient safety, and decreased
costs can be realised. While data suggest that eRx rates
are currently low, the latest trends indicate increased
adoption by the community. With increased edu-
cation of patients and providers, many of the per-
ceived barriers can be reduced, leading to increased
eRx rates and all the beneﬁts therein.
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